Oric Pharmaceuticals (NASDAQ:ORIC) reported updated Phase 1b data for enozertinib in previously untreated patients with ...
Verywell Health on MSN
How kidney disease is diagnosed
Medically reviewed by Matthew Wosnitzer, MD Key Takeaways The main tests for kidney disease are an estimated glomerular filtration rate (eGFR) blood test and a urine albumin-to-creatinine ratio (UACR) ...
GSK (LSE:GSK) agreed an exclusive global licence with HUTCHMED for KRAS-EGFR antibody drug conjugate HMPL-A830, excluding ...
Launch expands AstraZeneca’s commitment to addressing substantial unmet need across the spectrum of EGFR-mutated lung cancer ...
Sunvozertinib is FDA approved for patients with NSCLC with EGFR exon 20 insertion mutations that progressed on or after platinum-based chemotherapy. The oral EGFR inhibitor sunvozertinib (Zegfrovy) is ...
Depending on dose, firmonertinib shrank tumors in 43% to 68% of patients as a first treatment for EGFR PACC-mutant lung ...
Please provide your email address to receive an email when new articles are posted on . Patients with an eGFR below the 25th percentile of distribution for their age and sex had greater risks for ...
Finding out you have epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC) is a shock for anyone. You’ll have a lot to process and learn about your cancer and how your ...
Do not classify mechanically based on eGFR aloneWhen checking renal function during a health examination, it is important not to judge based solely on a single eGFR value, but to look at age, urinary ...
A new review in Genes & Diseases outlines how co-targeting EGFR alongside other tumor-driving molecules, delivered via ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results